Save

VIDEO: Impact of COVID-19 on IBD, clinical trials

By Stephen B. Hanauer, MD Source/Disclosures Source: Healio interview ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on . Please provide your email address to receive an email when new articles are posted on Subscribe ADDED TO EMAIL ALERTS You've successfully added to your alerts. You will receive an email when new content is published.



Click Here to Manage Email Alerts You've successfully added to your alerts. You will receive an email when new content is published.



Click Here to Manage Email Alerts



Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.



Back to Healio

In this exclusive video series, Stephen B. Hanauer, MD, medical director of the Digestive Health Center at Northwestern University Feinberg School of Medicine, discusses the impact of COVID-19 on the world of gastroenterology. In this video, he told Healio Gastroenterology and Liver Disease about how it has affected patients with inflammatory bowel disease, as well as clinical trials.